<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05125185</url>
  </required_header>
  <id_info>
    <org_study_id>304/PPSP/6315140</org_study_id>
    <nct_id>NCT05125185</nct_id>
  </id_info>
  <brief_title>The Effectiveness of USM-Insulin Adherence Module (U-IAM) for Type 2 Diabetes in Improving Insulin Adherence, Glycemic Control and Inflammation</brief_title>
  <official_title>The Effectiveness of USM-Insulin Adherence Module (U-IAM) for Type 2 Diabetes in Improving Insulin Adherence, Glycemic Control and Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiti Sains Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universiti Sains Malaysia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to the most current local data, the rate of patient's adherence to insulin&#xD;
      injections is very low. A recent cross sectional study in Klinik Pakar Perubatan (KPP)&#xD;
      Hospital Universiti Sains Malaysia (HUSM) among 355 patients with Type 2 diabetes treated&#xD;
      with insulin showed only 19% of patients adhered to their insulin regime with the mean&#xD;
      fasting plasma glucose of 10mmol/L and mean HbA1C of 10.0%. This condition may lead to&#xD;
      undesirable health consequences.&#xD;
&#xD;
      Patients education has been showed to improved adherence. Among the 355 participants involved&#xD;
      in the study, 82% of the patients have received consultation by diabetic educators yet their&#xD;
      glycemic control were suboptimal. A new approaches using a module-based counseling that&#xD;
      emphasized on adherence has been developed and the effectiveness of the counseling need to be&#xD;
      evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      General objective: To determine the effect of USM-insulin adherence module (U-IAM)-based&#xD;
      counseling on the insulin adherence, glycemic control and inflammatory markers in&#xD;
      poorly-controlled type 2 diabetes mellitus patients on insulin therapy.&#xD;
&#xD;
      Specific objective:&#xD;
&#xD;
        1. To determine within group changes and between group differences of insulin adherence&#xD;
           score (using IAQDM) between patients in intervention and control group at baseline, 3rd&#xD;
           month and 6th month&#xD;
&#xD;
        2. To determine within group changes and between group differences of FBS and HbA1c between&#xD;
           patients in intervention and control group at baseline, 3rd month and 6th month.&#xD;
&#xD;
        3. To determine within group changes and between group differences of HsCRP and VCAM-1&#xD;
           between patients in intervention and control group at baseline, 3rd month and 6th month.&#xD;
&#xD;
        4. To identify factors associated with nonadherence (before starting of intervention) among&#xD;
           patients on insulin such as sociodemographic, SMBG and treatment factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>comparing effect of counseling to insulin adherence, FBS, HbA1c, HsCRP and VCAM-1</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of insulin adherence score</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of insulin adherence score</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Fasting Blood Sugar</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Fasting Blood Sugar</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of HbA1c</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of HbA1c</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of HsCRP</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of VCAM-1</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Diabetes Type 2 on Insulin</condition>
  <arm_group>
    <arm_group_label>current counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>counseling by diabetic educators on insulin injection technique, hypoglycemia, SMBG and insulin dose optimization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>counseling using module</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>counseling by diabetic educators on insulin injection technique, hypoglycemia, SMBG, insulin dose optimization and subtopic on nonadherence</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>The Effectiveness of USM-Insulin Adherence Module (U-IAM) for Type 2 Diabetes in Improving Insulin Adherence, Glycemic Control and Inflammation</intervention_name>
    <description>To study the effect of counseling using USM-Insulin Adherence Module (U-IAM) for Type 2 Diabetes in improving Insulin Adherence, Glycemic Control and Inflammation</description>
    <arm_group_label>counseling using module</arm_group_label>
    <arm_group_label>current counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 to 65 years&#xD;
&#xD;
          -  have been diagnosed with Type 2 Diabetes Mellitus&#xD;
&#xD;
          -  Patients treated with insulin injections for at least 1 year on either basal insulin,&#xD;
             basal plus prandial or basal bolus insulin&#xD;
&#xD;
          -  HbA1c between 8 % and 15%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  do not understand Malay language or illiterate&#xD;
&#xD;
          -  have severe diabetes complications such as chronic kidney disease, heart failure&#xD;
&#xD;
          -  recurrent hypoglycemia or hypoglycemia unawareness&#xD;
&#xD;
          -  body mass index (BMI) â‰¥ 40kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universiti Sains Malaysia</name>
      <address>
        <city>Kubang Kerian</city>
        <state>Kelantan</state>
        <zip>16150</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>aida zainudin, MD</last_name>
      <phone>60179005539</phone>
      <email>draidamaziha@usm.my</email>
    </contact>
    <contact_backup>
      <phone>097676131</phone>
    </contact_backup>
    <investigator>
      <last_name>Wan Mohd Izani Wan Mohamed, MBChB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>November 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universiti Sains Malaysia</investigator_affiliation>
    <investigator_full_name>Aida Maziha Binti Zainudin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

